Enveda Biosciences

Boulder, CO

Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologies systematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration. Enveda, launched in 2019, is based in San Francisco, California.

Claim this profile

Employbl Premium

Get the inside track on Enveda Biosciences

Premium profiles, AI research on tech stack and hiring, 61,000+ ATS job listings, saved searches, and an AI chat that knows the SF startup scene.

AI chat about Enveda Biosciences's culture, stack, and interview process
Save jobs and get alerts on new openings
Full premium profiles across our company index
7-day free trial, then $25/mo. Cancel anytime.

Start free trial →Already have an account? Sign in

Company Details

Founded: 2019
Employees: Between 50 - 500 employees
Raised: $379,900,000
Headquarters Location: Boulder, CO
Public: No
Acquired: No
CEO: Viswa Colluru
Founders: Pieter Dorrestein
Viswa Colluru

Company Collections

These are collections Enveda Biosciences is a part of. Click on the collection name to view similar companies.

Enveda Biosciences' Industries

Software Companies

Medical Organizations

Biotechnology Companies

Enveda Biosciences' Tech Stack

Microsoft Azure

Enveda Biosciences' Investors

Enveda Biosciences Headquarters Location

Boulder, CO, 80310

Loading map…

Total Amount Raised: $379,900,000

Enveda Biosciences' Investors

Enveda Biosciences Funding Rounds

Series C
$20,000,000
Feb 26, 2025
Series C
$20,000,000
Feb 25, 2025
Series C Investors
Sanofi
Series C
$130,000,000
Nov 21, 2024
Series C
$130,000,000
Nov 20, 2024
Series C Investors
FPV Ventures
Kinnevik
The Nature Conservancy
True Ventures
Lux Capital
Dimension Capital Management
Lingotto
Henry Kravis
Premji Invest
Baillie Gifford
Cresset
Series B
$55,000,000
Jun 14, 2024
Series B
$55,000,000
Jun 13, 2024
Series B Investors
Lingotto
True Ventures
Microsoft
FPV Ventures
Albert Azout
Premji Invest
Jazz Venture Partners
The Nature Conservancy
Kinnevik
Series B
$51,000,000
Apr 20, 2023
Series B
$51,000,000
Apr 19, 2023
Series B Investors
Kinnevik
True Ventures
Wireframe Ventures
FPV Ventures
Dimension
Henry Kravis
Series B
$55,000,000
Dec 21, 2022
Debt Financing
$13,000,000
Dec 21, 2022
Series B
$55,000,000
Dec 20, 2022
Series B Investors
Dimension
FPV Ventures
Jazz Venture Partners
Amino Collective
True Ventures
Allen & Company
Albert Azout
Lux Capital
Possible Ventures
Hummingbird Ventures
Wireframe Ventures
Two Sigma Ventures
Debt Financing
$13,000,000
Dec 20, 2022
Debt Financing Investors
First Citizens Bank
Series A
$51,000,000
Jun 22, 2021
Series A
$51,000,000
Jun 21, 2021
Series A Investors
Lux Capital
Catalio Capital Management
Wireframe Ventures
True Ventures
Hummingbird Ventures
Chris Gibson
Lifeforce Capital
Two Sigma Ventures
Village Global
Matt De Silva
Bioverge
Seed
$4,900,000
Aug 11, 2020
Seed
$4,900,000
Aug 10, 2020
Seed Investors
True Ventures
Village Global
Chris Gibson
Wireframe Ventures
Vertical Partners

Funding info provided by Diffbot.

Enveda Biosciences Reviews

Based on 0 reviews

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Enveda Biosciences.